Cite
APA Citation
Lundkvist, P., Sjöström, C. D., Amini, S., Pereira, M. J., Johnsson, E., & Eriksson, J. W. (2017). dapagliflozin once‐daily and exenatide once‐weekly dual therapy: A 24‐week randomized, placebo‐controlled, phase II study examining effects on body weight and prediabetes in obese adults without diabetes. Diabetes, obesity & metabolism, 19(1), 49–60. http://access.bl.uk/ark:/81055/vdc_100039978042.0x00002d